These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1342291)
1. Lipoprotein(a). Link between structure and pathology. Scanu AM Ann Epidemiol; 1992 Jul; 2(4):407-12. PubMed ID: 1342291 [TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a): structural implications for pathophysiology. Koschinsky ML; Marcovina SM Int J Clin Lab Res; 1997; 27(1):14-23. PubMed ID: 9144023 [TBL] [Abstract][Full Text] [Related]
3. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process. Anglés-Cano E Braz J Med Biol Res; 1997 Nov; 30(11):1271-80. PubMed ID: 9532233 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a). A potential bridge between the fields of atherosclerosis and thrombosis. Scanu AM Arch Pathol Lab Med; 1988 Oct; 112(10):1045-7. PubMed ID: 2972266 [TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a) and atherosclerosis. Scanu AM; Lawn RM; Berg K Ann Intern Med; 1991 Aug; 115(3):209-18. PubMed ID: 1829339 [TBL] [Abstract][Full Text] [Related]
7. Genetic basis and pathophysiological implications of high plasma Lp(a) levels. Scanu AM J Intern Med; 1992 Jun; 231(6):679-83. PubMed ID: 1535652 [TBL] [Abstract][Full Text] [Related]
8. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches. Chapman MJ; Guérin M; Bruckert E Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339 [TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification. Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784 [TBL] [Abstract][Full Text] [Related]
11. [Lipoprotein (a): a genetic risk factor with atherogenic and thrombogenic properties]. Vaverková H; Novotný D Vnitr Lek; 1995 Sep; 41(9):618-23. PubMed ID: 7483354 [TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a): its inheritance and molecular basis of its atherothrombotic role. Scanu AM Mol Cell Biochem; 1992 Aug; 113(2):127-31. PubMed ID: 1387699 [TBL] [Abstract][Full Text] [Related]
13. Changes in plasma triglyceride levels shift lipoprotein(a) density in parallel with that of LDL independently of apolipoprotein(a) size. Nakajima K; Hinman J; Pfaffinger D; Edelstein C; Scanu AM Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1238-43. PubMed ID: 11451758 [TBL] [Abstract][Full Text] [Related]
14. Lp(a) as a marker for coronary heart disease risk. Scanu AM Clin Cardiol; 1991 Feb; 14(2 Suppl 1):I35-9. PubMed ID: 1828399 [TBL] [Abstract][Full Text] [Related]
15. Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits. Ichikawa T; Unoki H; Sun H; Shimoyamada H; Marcovina S; Shikama H; Watanabe T; Fan J Am J Pathol; 2002 Jan; 160(1):227-36. PubMed ID: 11786416 [TBL] [Abstract][Full Text] [Related]
19. Studies of lipoprotein (a) and high density lipoproteins in transgenic mice. Rubin EM Atherosclerosis; 1994 Oct; 110 Suppl():S77-81. PubMed ID: 7857389 [TBL] [Abstract][Full Text] [Related]
20. The role of lipoprotein(a) in atherogenesis and thrombosis. Hajjar KA; Nachman RL Annu Rev Med; 1996; 47():423-42. PubMed ID: 8712793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]